Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

I0782

Sigma-Aldrich

Imazodan

≥99% (HPLC)

Synonym(s):

4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinone, Cl 914

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C13H12N4O
CAS Number:
Molecular Weight:
240.26
MDL number:
UNSPSC Code:
41106305
PubChem Substance ID:

assay

≥99% (HPLC)

color

yellow, powder

solubility

DMSO: 50 mg/mL, clear, yellow

SMILES string

O=C1CCC(=NN1)c2ccc(cc2)-n3ccnc3

InChI

1S/C13H12N4O/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17/h1-4,7-9H,5-6H2,(H,16,18)

InChI key

VXMYWVMXSWJFCV-UHFFFAOYSA-N

Gene Information

human ... PDE3A(5139)
rat ... Pde3a(50678)

Biochem/physiol Actions

Selective phoshodiesterase III (PDE3) inhibitor.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

High-performance liquid chromatographic assay of imazodan, methylparaben and propylparaben in imazodan injection.
T Geria et al.
Journal of chromatography, 450(3), 407-413 (1988-10-26)
S E Sadler
Molecular endocrinology (Baltimore, Md.), 5(12), 1947-1954 (1991-12-01)
Insulin-like growth factor-I (IGF-I) stimulated Xenopus laevis oocyte ribosomal S6 kinase activity 5- to 10-fold, with an apparent EC50 of 0.8 +/- 0.1 nM after 90 min of hormone treatment. IGF-I-stimulated enzyme activity was inhibited by treatment of oocytes with
[Phosphodiesterase inhibition as a new positive-inotropic principle].
A Hartmann et al.
Deutsche medizinische Wochenschrift (1946), 111(51-52), 1971-1977 (1986-12-19)
Determination of 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography.
A G Hayes et al.
Journal of chromatography, 336(2), 446-451 (1984-12-12)
R E Weishaar et al.
Cardiovascular drugs and therapy, 3(1), 29-42 (1989-03-01)
Intense efforts during the last decade to identify a useful positive inotropic agent to replace digitalis for the treatment of congestive heart failure have led to the discovery of several dozen potential substitutes, of which a number are currently undergoing

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service